You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

beta-Thalassemia

Showing 26 - 50 of 3,307
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen University General Hospital
May 8, 2023

Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))

Recruiting
  • Transfusion Dependent Beta-Thalassemia
  • GMCN-508B (LentiRed)
  • Nanning, Guangxi, China
    The affiliated hospital of guangxi medical university
Feb 28, 2023

Sickle Cell Disease, Sickle Cell Trait, Beta-Thalassemia Trial (High performance liquid chromatography, Automated sickling test,

Not yet recruiting
  • Sickle Cell Disease
  • +4 more
  • High performance liquid chromatography
  • +5 more
  • (no location specified)
Aug 17, 2022

Thalassemia Major Trial (n-acetylcystine)

Not yet recruiting
  • Thalassemia Major
  • (no location specified)
Mar 9, 2023

Human Biospecimens for Basic and Clinical Research Into Globin

Recruiting
  • Alpha and Beta Thalassemia
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

    Recruiting
    • β-thalassemia
    • β-globin restored autologous hematopoietic stem cells
    • Shenzhen, Guangdong, China
      Shenzhen Children's Hospital
    Feb 24, 2023

    ß-thalassemia Trial in Shanghai (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • Shanghai, China
      Shanghai Ruijin Hospital
    Mar 16, 2023

    Beta-Thalassemia Trial in Bulgaria, Israel, United States (VIT-2763 60 mg QD, VIT-2763 60 mg BID, VIT-2763 120 mg BID)

    Withdrawn
    • Beta-Thalassemia
    • VIT-2763 60 mg QD
    • +3 more
    • Whittier, California
    • +6 more
    Nov 7, 2022

    Alpha-Thalassemia, Alpha Thalassemia Major, Alpha Thalassemia Minor Trial in San Francisco

    Recruiting
    • Alpha-Thalassemia
    • +2 more
      • San Francisco, California
        University of California San Francisco
      Oct 7, 2022

      Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

      Not yet recruiting
      • Sickle Cell Disease
      • +5 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jun 21, 2023

      Beta Thalassemia Major, Beta Thalassemia Intermedia Trial in Worldwide (SOTATERCEPT (ACE-011))

      Completed
      • Beta Thalassemia Major
      • Beta Thalassemia Intermedia
      • SOTATERCEPT (ACE-011)
      • Créteil, France
      • +14 more
      Aug 18, 2022

      Beta-Thalassemia Trial in China (BRL-101)

      Recruiting
      • Beta-Thalassemia
      • Guangzhou, Guangdong, China
      • +3 more
      Nov 7, 2022

      Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Nashville (CTX001)

      Recruiting
      • Beta-Thalassemia
      • +4 more
      • CTX001
      • Nashville, Tennessee
      • +5 more
      Feb 2, 2023

      Transfusion Dependent Beta-thalassemia Trial in United States (ST-400 Investigational product)

      Active, not recruiting
      • Transfusion Dependent Beta-thalassemia
      • ST-400 Investigational product
      • Los Angeles, California
      • +5 more
      Jul 6, 2022

      Pulmonary Functions and Physical Fitness in ß-thalassemia

      Recruiting
      • β-Thalassemia
      • +2 more
      • no intervention
      • Cairo, Egypt
        Esraa Elsayed
      Aug 8, 2022

      After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell

      Recruiting
      • Blood and Lymphatic Diseases
      • Detroit, Michigan
        Investigational Site Number :8400001
      Jul 6, 2022

      QoL of Pediatric Patients After HSCT and Its Influencing Factors

      Not yet recruiting
      • Thalassemia Major
      • Acute Leukemia
      • Conventional nursing
      • Guangzhou, Guangdong, China
        Sun Yat-sen Memorial Hospital, Sun Yat-sen University
      Sep 4, 2023

      Transfusion Dependent Beta-Thalassaemia Trial in Nanning (ET-01)

      Recruiting
      • Transfusion Dependent Beta-Thalassaemia
      • ET-01
      • Nanning, Guangxi, China
        PLA 923 Hospital
      Mar 2, 2023

      Beta-Thalassemia, Thalassemia, Hematologic Diseases Trial (CTX001)

      Not yet recruiting
      • Beta-Thalassemia
      • +6 more
      • CTX001
      • (no location specified)
      Jul 26, 2022

      Minimisation Measures for REBLOZYL Among Healthcare

      Active, not recruiting
      • Myelodysplastic Syndromes
      • Beta-thalassemia
        • City, State, Austria
          Local Institution
        Aug 4, 2022

        The Prevelence of IVS 1-6 [HBB:c.92 +6 T-C] Gene Mutation in

        Not yet recruiting
        • Beta-Thalassemia
        • ARMS
        • (no location specified)
        May 10, 2022

        ß Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

        Active, not recruiting
        • β Thalassemia Major
        • γ-globin reactivated autologous hematopoietic stem cells
        • Shanghai, Shanghai, China
          Shanghai Bioray Laboratories Inc.
        Oct 9, 2022

        Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia, Hemoglobinopathies Trial in San Francisco (in utero hematopoietic

        Enrolling by invitation
        • Alpha Thalassemia Major
        • +8 more
        • in utero hematopoietic stem cell transplantation
        • San Francisco, California
          University of California
        Oct 28, 2022

        Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)

        Active, not recruiting
        • Beta-Thalassemia
        • +4 more
        • CTX001
        • Stanford, California
        • +11 more
        Nov 30, 2022

        Thalassemia Major, Transfusion-dependent Anemia Trial in Guangzhou (Luspatercept Injectable Product)

        Recruiting
        • Thalassemia Major
        • Transfusion-dependent Anemia
        • Luspatercept Injectable Product
        • Guangzhou, Guangdong, China
          The second affiliated hospital of Sun Yat-sen University
        Jul 15, 2022